Orly Einav-Rubashkin

Orly Einav-Rubashkin has extensive work experience in the pharmaceutical industry, having held various positions at Dexcel Pharma and Protalix Biotherapeutics. At Dexcel Pharma, they worked as a Product Scientific Support Manager and later as Head of Continuous Improvement, QA. Orly also served as Head of Technology Development, overseeing the development of new technologies. At Protalix Biotherapeutics, they worked as a QA Manager. Currently, they are Head of QA & RA at Imagindairy, a position they assumed in 2023. Overall, Orly Einav-Rubashkin has extensive experience in quality assurance, continuous improvement, project management, and technology development in the pharmaceutical industry.

Orly Einav-Rubashkin earned their Bachelor of Science in Biotechnology and Food Engineering from Technion - Israel Institute of Technology in 2001. Orly later obtained their Master of Engineering in the same field from the same institution in 2009. At some point, they also studied Cannabis for Research and Medical Use at Tel Aviv University, but the exact timeline and degree obtained are unspecified.